Edaravone dexborneol for recent ischemic stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a medicine called edaravone dexborneol to see if it helps people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel). The medicine is given within 48 hours of the stroke, and the study will compare how well it works and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your stroke was caused by a blocked blood vessel (not bleeding) and you can start treatment within 48 hours of the stroke starting.
- Your stroke is moderately severe, meaning you have noticeable weakness in an arm or leg.
- You were able to take care of yourself before this stroke (no major disability).
- You have not received a clot-busting drug or a mechanical clot removal for this stroke.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a medicine called edaravone can help people who recently had a mild or moderate stroke caused by a blocked blood vessel in the brain. It aims to see if the drug improves recovery when given within the first two days after stroke symptoms start.
This trial tests a medication called edaravone dexborneol that is given under the tongue while you are being transferred to a hospital for a procedure to remove a blood clot from your brain. It is hoped that this medication can help protect your brain during the journey and improve recovery after the stroke.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests whether a new drug called QD202 can help protect the brain and improve recovery when given alongside standard clot-busting therapy (thrombolysis) for acute ischemic stroke. You would be in the trial if you had a stroke in the last 24 hours and are receiving or planning to receive thrombolytic treatment.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.